Evidence map›Paper›PMID 36707069›Full record

ArticleAging2023

Pathological trajectory in the Ts65Dn model of Down syndrome.

Savannah Tallino, Wendy Winslow, Ramon Velazquez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Savannah TallinoArizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA.
Wendy WinslowArizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA.
Ramon VelazquezArizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA.

Funding

Identify common mechanisms of neurodegeneration between Alzheimer's disease and Down syndromeR01AG059627 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI VELAZQUEZ, RAMON · 2018 to 2022
$3.1M
NIA NIH HHS R01 AG059627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Down SyndromeAgingAnimalsDisease Models, AnimalHumansMiceMice, Transgenicamyloid-betacholinergicDown syndromeTs65Dn

Identifiers

PMID36707069
PMCPMC9925689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.